The latest data from the American Society of Health-System Pharmacists reports that the active number of drug shortages in the U.S. has decreased to 271, down from a high of 323 in the first quarter ...

Questionable prescribing of CNS-active drugs persists ...

Please provide your email address to receive an email when new articles are posted on . Mebeverine was not superior to placebo, with similar treatment success and symptom relief reported between ...

After reaching a record high in 2024, the number of active drug shortages is declining, according to a recent American Society of Health-System Pharmacists report. However, while new shortages have ...

The number of active drug shortages is 214. Long-standing shortages are beginning to resolve. Almost three-quarters of all active shortages (72%) started in 2022 or later. The workload required to ...

Skin pigmentation may act as a "sponge" for some medications, potentially influencing the speed with which active drugs reach their intended targets, a pair of scientists report in a perspective ...

The European Medicines Agency (EMA) has confirmed a suspension notice for Oxbryta (voxelotor, Pfizer), which is used to treat sickle cell disease (SCD). The medicines regulator said that a higher rate ...